Immunotherapy in head and neck cancer: aiming at EXTREME precision

Immunotherapy in head and neck cancer: aiming at EXTREME precision

Abstract Background Locoregionally advanced, recurrent, and metastatic squamous cell carcinomas of the head and neck (SCCHN) remain difficult to treat disease entities, in which systemic treatment often forms an integral part of their management. Immunotherapy is based on functional restoration of t...

Full description

Bibliographic Details
Main Authors: Petr Szturz, Jan B. Vermorken
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Medicine
Subjects:
Head and neck cancer
Recurrent
Metastatic
Targeted therapy
Immunotherapy
Cetuximab
Online Access:http://link.springer.com/article/10.1186/s12916-017-0879-4

Internet

http://link.springer.com/article/10.1186/s12916-017-0879-4

Similar Items